These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 737133)

  • 21. Trimethylpsoralen bath PUVA is a remittive treatment for psoriasis vulgaris. Evidence that epidermal immunocytes are direct therapeutic targets.
    Coven TR; Murphy FP; Gilleaudeau P; Cardinale I; Krueger JG
    Arch Dermatol; 1998 Oct; 134(10):1263-8. PubMed ID: 9801682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PUVA therapy for photosensitive psoriasis.
    Ros AM; Wennersten G
    Acta Derm Venereol; 1987; 67(6):501-5. PubMed ID: 2451375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
    Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trioxsalen vs methoxsalen in the treatment of psoriasis.
    Skogh M
    Arch Dermatol; 1978 Sep; 114(9):1399. PubMed ID: 686760
    [No Abstract]   [Full Text] [Related]  

  • 25. Photochemotherapy: a new promising chemical derivative.
    Willis I
    Arch Dermatol Res; 1982; 272(3-4):251-6. PubMed ID: 7165333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis.
    Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J
    Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system.
    Parrish JA; Fitzpatrick TB; Shea C; Pathak MA
    Arch Dermatol; 1976 Nov; 112(11):1531-4. PubMed ID: 984858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis.
    Calzavara-Pinton PG; Ortel B; Hönigsmann H; Zane C; De Panfilis G
    Dermatology; 1994; 189(3):256-9. PubMed ID: 7949478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photochemotherapy for psoriasis.
    Roenigk HH; Martin JS
    Arch Dermatol; 1977 Dec; 113(12):1667-70. PubMed ID: 596894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of phototoxicity in trioxysalen bath psoralen plus ultraviolet A photochemotherapy.
    Snellman E; Rantanen T
    Acta Derm Venereol; 2001; 81(3):171-4. PubMed ID: 11558870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis.
    Collins P; Rogers S
    Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local photochemotherapy in nodular prurigo.
    Väätäinen N; Hannuksela M; Karvonen J
    Acta Derm Venereol; 1979; 59(6):544-7. PubMed ID: 94220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultraviolet A phototherapy and trimethylpsoralen UVA photochemotherapy in polymorphous light eruption--a controlled study.
    Berg M; Ros AM; Berne B
    Photodermatol Photoimmunol Photomed; 1994 Aug; 10(4):139-43. PubMed ID: 7803223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of trimethylpsoralen against UV-B erythema.
    Agache PG; Coupez L
    Arch Dermatol Res; 1980; 268(1):85-9. PubMed ID: 7416800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trioxsalen bath and ultraviolet light treatment of psoriasis.
    Fischer T; Jublin L
    Arch Dermatol; 1977 Jun; 113(6):852. PubMed ID: 869562
    [No Abstract]   [Full Text] [Related]  

  • 36. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis.
    Hofer A; Fink-Puches R; Kerl H; Quehenberger F; Wolf P
    Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):1-5. PubMed ID: 16436174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA.
    Takashima A; Yamamoto K; Kimura S; Takakuwa Y; Mizuno N
    Br J Dermatol; 1991 Jan; 124(1):37-42. PubMed ID: 1993143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of the relationship between photosensitizing and therapeutic activity of 4,5',8-trimethylpsoralen, and its major metabolite 4,8-dimethyl, 5'-carboxypsoralen.
    Pathak MA; Marciani MS; Guiotto A; Rodighiero G
    J Invest Dermatol; 1983 Dec; 81(6):533-9. PubMed ID: 6644095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations after bath treatment and oral administration of trioxsalen.
    Fischer T; Hartvig P; Bondesson U
    Acta Derm Venereol; 1980; 60(2):177-79. PubMed ID: 6155034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.